title: Panitumumab: A safe option for oncologic patients sensitized to galactose-α-1,3-galactose.
authors.affiliation: Department of Dermatology, Eberhard Karls University, Tübingen, Germany.
authors.forename: Patricia
authors.initials: P
authors.lastname: Caponetto
authors.affiliation: Department of Dermatology, Eberhard Karls University, Tübingen, Germany; Department of Dermatology and Allergy, Biederstein, Technical University, Munich, Germany.
authors.forename: Tilo
authors.initials: T
authors.lastname: Biedermann
authors.affiliation: Department of Dermatology, Eberhard Karls University, Tübingen, Germany. Electronic address: amir.yazdi@med.uni-tuebingen.de.
authors.forename: Amir S
authors.initials: AS
authors.lastname: Yazdi
authors.affiliation: Department of Dermatology, Eberhard Karls University, Tübingen, Germany.
authors.forename: Jörg
authors.initials: J
authors.lastname: Fischer
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005690:Galactose / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007073:Immunoglobulin E / Q000276:immunology; D000077544:Panitumumab
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007073:Immunoglobulin E; D000077544:Panitumumab; D005690:Galactose